Table 1.
Randomized controlled trials of local ablative treatment for oligometastatic disease.
| NCT No. | Name | Year | Histology | Population | Number of patients | Intervention | Synchronicity |
|---|---|---|---|---|---|---|---|
| NCT02045446 | Iyengar | 2018 | NSCLC | ITT | 29 | SBRT | Sync & Meta |
| NCT01446744 | SABR-COMET | 2019 | Mixed | ITT | 99 | SBRT | Meta |
| NCT01558427 | STOMP | 2018 | Prostate | ITT | 62 | SBRT/Surgery | Meta |
| NCT02680587 | ORIOLE | 2020 | Prostate | ITT | 54 | SBRT | Meta |
| NCT01725165 | Gomez | 2016 | NSCLC | ITT | 49 | RT/ Surgery | Sync & Meta |
| NCT02893332 | SINDAS | 2022 | NSCLC | ITT | 133 | SBRT | Sync |
NCT National clinical trial, NSCLC Non-small cell lung cancer, SBRT stereotactic body radiation therapy, CRT Chemo-radiotherapy, RT Radiotherapy, ITT Intention-to-treat, Sync Synchronicity, Meta Metachronous.